Integer to Exhibit at NANS 2023 Annual Meeting
PLANO, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, […]
Milestone Scientific Announces TEKMIKA as Exclusive STA Single Tooth Anesthesia System® Distributor in Brazil
ROSELAND, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments […]
Greystone Housing Impact Investors LP Announces Sales of Vantage at Stone Creek and Vantage at Coventry
OMAHA, Neb., Jan. 10, 2023 (GLOBE NEWSWIRE) — Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced today that […]
Tri Pointe Homes, Inc. Announces Fourth Quarter 2022 Earnings Release and Conference Call Date
INCLINE VILLAGE, Nev., Jan. 10, 2023 (GLOBE NEWSWIRE) — Tri Pointe Homes, Inc. (NYSE: TPH) announced today that it will […]
BiomX To Present at H.C. Wainwright 1st Annual Investor Conference on Bacteriophage
NESS ZIONA, Israel, Nov. 29, 2022 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage […]
STMicroelectronics reveals 100-Watt wireless power receiver for fastest Qi-compliant charging
STMicroelectronics reveals 100-Watt wireless power receiverfor fastest Qi-compliant charging Unique high-power capability boosts mobile user experience, brings new opportunities for […]
IDT Corporation to Present at Sidoti December Small Cap Virtual Investor Conference
NEWARK, NJ, Nov. 29, 2022 (GLOBE NEWSWIRE) — IDT Corporation (NYSE: IDT), a global provider of fintech, cloud communications, and […]
Apollo Names Shawn T. Wooden Chief Public Pension Strategist and Partner
NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) — Apollo Global Management, Inc. (NYSE: APO) today announced the appointment of Shawn […]
Acuity Brands Announces 2022 EarthLIGHT Report
Atlanta, Nov. 29, 2022 (GLOBE NEWSWIRE) — Today, Acuity Brands, Inc. (NYSE: AYI) (“Acuity”), a market-leading industrial technology company released […]
Interim Data from Ambrx’s Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium
SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company […]
